From Idea to Innovation, Ambition to Action, Vision to Value, Potential to Panacea. A future Star?

Calling at scientists and entrepreneurs; 2018 Accelerator application is now open for an opportunity to win a non-dilutive package worth £100K. Deadline 17th Feb.

apply now
New Knowledge Partnership for PanaceaStars Feb, 6th. 2018 Author :Stavroula Bitsi













New Knowledge Partnership for PanaceaStars


The PanaceaStars Accelerator programme aims to source the very best early-stage start-ups both nationally and internationally across our BioStars (Life Sciences/Healthcare), AIStars (Artificial Intelligence) and TEMStars (Technology, Engineering and Mathematics) streams. Selected start-ups undergo an intensive de-risking and development phase, including workshops, bootcamps and training sessions. By bringing our teams into close contact with the very best academic and industrial mentors (including scientific, investment, legal and consultancy) during this programme, start-ups experience the very best environment in which to create a successful business. The culmination of the programme in June 2018 sees the crowning of the winning team at a Grand Finale Gala dinner, at which the non-dilutive prize fund of £30,000 is awarded, along with ongoing mentorship and development space. The deadline for applying to PanaceaStars 2018 Accelerator programme is 17th February.


By establishing a knowledge partnership with McKinsey & Company, PanaceaStars further enhances the quality of mentoring and business development resources available to start-ups, and develops the network of industry leading professionals available for interaction with teams. This will not only aid in the development of individual start-ups, but also help to optimise team value for potential future investment by Panacea’s funding arm, Panacea Ventures.


Dr Tobias Silberzahn, Partner at McKinsey & Company, said “In the healthcare innovation space, we see a lot of promising start-ups with great ideas, and usually lots of questions about commercialization, scale-up and the overall health system perspective. We are looking forward to addressing some of these questions with the start-ups”.


Mina Bekheet, CEO and Founder of the Panacea group, said “I am particularly excited by this partnership, as it gives our start-ups an opportunity to network with, and be mentored by, professionals with top-notch industry expertise. This guarantees to place our PanaceaStars start-ups in the best possible position moving forwards. Such partnerships are crucial in building on our already leading position as an all-inclusive deep science translation programme, and raises the quality of our offering to start-ups and, in turn, their future offerings to investors”.


For full details of the PanaceaStars programme, and all our upcoming events, please visit our website.


Notes for editors:


PanaceaStars is Panacea Innovation’s flagship vehicle for mining, de-risking, accelerating, growing and funding early-stage deep science companies. We maintain a core focus on supporting great innovators in their drive to develop proof-of-concepts from the earliest stages and proving they have what it takes to scale their ideas.


McKinsey & Company is a global management consulting firm, deeply committed to helping institutions in the private, public and social sectors achieve lasting success. For 90 years, our primary objective has been to serve as our clients’ most trusted external advisor. With consultants in over 110 locations in over 60 countries, across industries and functions, we bring unparalleled expertise to clients anywhere in the world. We work closely with teams at all levels of an organization to shape winning strategies, mobilize for change, build capabilities and drive successful execution.


Stavroula Bitsi

mckinsey entrepreneruship
WE ARE THE GLOBE’S EARLY STAGE DEEP SCIENCE TRANSLATION AND INVESTMENT HOME. We work with the world’s best minds to kickstart and grow ideas into products that address real humankind needs via novel science and technology. We provide the complete toolkit of early stage investment, R&D, business support, mentorship, incubation and top-notch industry partnerships.